Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 4, Multi-National, Randomized, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of Varenicline Compared To Placebo For Smoking Cessation Through Reduction

NCT01370356 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT01370356
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01370356 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 4, Multi-National, Randomized, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of Varenicline Compared To Placebo For Smoking Cessation Through Reduction
Lead sponsor
Pfizer
Phase
Phase 4
Overall status
Completed
Start date
July 31, 2011
Completion date
July 31, 2013
Enrollment
1,510 (actual)
Sites
65

Conditions

As the registry lists them; a condition with its own page is linked.

smoking cessation